Skip to main content

Animations

MJFF Publications

3681 - 3690 of 9117 Results
Title
Year
  • Year
  • 2026
  • 2025
  • 2018
  • 2017
  • 2018
  • 2004
  • 2025
  • 2021
  • 2011
  • 2018
  • Summary Details
    OPEN
    Title: Chemical tools for inhibition and activity-based profiling of glucocerebrosidase in vitro and in vivo
    Journal Name: Cell Chemical Biology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.chembiol.2026.07.007
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Evidence‐based standardized sample handling protocol for accurate blood‐based Alzheimer's disease biomarker measurement: Results and consensus of the Global Biomarker Standardization Consortium
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/alz.70752
    Citation Count: 22
  • Summary Details
    OPEN
    Title: Ubiquitin specific protease-13 independently regulates parkin ubiquitination and alpha-synuclein clearance in alpha-synucleinopathies
    Journal Name: Human Molecular Genetics
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/hmg/ddy365
    Citation Count: 81
  • Summary Details
    OPEN
    Title: Orthostatic hypotension in Parkinson disease: Impact on health care utilization
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2017.11.344
    Citation Count: 48
  • Summary Details
    OPEN
    Title: Investigation of serotonergic Parkinson's disease-related covariance pattern using [11C]-DASB/PET
    Journal Name: NeuroImage: Clinical
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.nicl.2018.05.022
    Citation Count: 31
  • Increased D1 dopamine receptor signaling in levodopa‐induced dyskinesia
    2004
    Summary Details
    RESTRICTED
    Title: Increased D1 dopamine receptor signaling in levodopa‐induced dyskinesia
    Journal Name: Annals of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/ana.20296
    Citation Count: 384
  • Summary Details
    OPEN
    Title: CHCHD2 mutant mice link mitochondrial deficits to PD pathophysiology
    Journal Name: Science Advances
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1126/sciadv.adu0726
    Citation Count: 3
  • Summary Details
    OPEN
    Title: A new alpha-synuclein missense variant (Thr72Met) in two Turkish families with Parkinson's disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.06.023
    Citation Count: 43
  • Summary Details
    OPEN
    Title: Lrrk2 p.Q1111H substitution and Parkinson’s disease in Latin America
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2011.05.003
    Citation Count: 17
  • Summary Details
    OPEN
    Title: Nigrostriatal pathology with reduced astrocytes in LRRK2 S910/S935 phosphorylation deficient knockin mice
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.nbd.2018.09.003
    Citation Count: 18
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.